An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers

International Wound Journal

Volumn 11, Issue 2, 2014, Pages 183-189

  Morimoto, Naoki ^a   Ito, Tatsuya ^b   Takemoto, Satoru ^a   Katakami, Mikiko ^b   Kanda, Norikazu ^a   Tada, Harue ^b   Tanaka, Shiro ^b   Teramukai, Satoshi ^b   Kawai, Katsuya ^a   Nakamura, Yoko ^a   Kasai, Yasunari ^b   Masayuki, Yokode ^b   Maekawa, Taira ^b   Shimizu, Akira ^b   Suzuki, Shigehiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Animal product free medium; Autologous fibroblast seeded cultured dermal substitute; Autologous serum; Diabetic foot ulcer

Indexed keywords

TRYPSIN; CULTURE MEDIUM;

ADULT; AGED; AMPUTATION; ANIMAL PRODUCT; ARTICLE; ARTIFICIAL SKIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DEBRIDEMENT; DIABETIC FOOT; DISEASE DURATION; FIBROBLAST SEEDED ARTIFICIAL DERMIS; FULL THICKNESS SKIN GRAFT; GANGRENE; GRANULATION TISSUE; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; SAFETY; SKIN AUTOGRAFT; WOUND HEALING; AMPUTATION STUMP; AUTOGRAFT; CASE REPORT; CULTURE MEDIUM; FIBROBLAST; HEEL; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; AMPUTATION STUMPS; AUTOGRAFTS; CULTURE MEDIA; DIABETIC FOOT; FIBROBLASTS; GRANULATION TISSUE; HEEL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN, ARTIFICIAL; WOUND HEALING;

EID: 84897064392     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.01064.x     Document Type: Article

References (30)

1. Vuorisalo S, Venermo M, Lepäntalo M. Treatment of diabetic foot ulcers. J Cardiovasc Surg 2009 ; 50: 275 - 91. Review.
2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005 ; 293: 217 - 28.
3. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 2007 ; 3: 65 - 76.
4. Game FL, Hinchliffe RJ, Apelqvist J, Armstrong DG, Bakker K, Hartemann A, Löndahl M, Price PE, Jeffcoate WJ. A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2012 ; 28 (Suppl 1): 119 - 41.
5. Priya SG, Jungvid H, Kumar A. Skin tissue engineering for tissue repair and regeneration. Tissue Eng Part B Rev 2008 ; 14 (1): 105 - 18. Review.
6. Uccioli L, Giurato L, Ruotolo V, Ciavarella A, Grimaldi MS, Piaggesi A, Teobaldi I, Ricci L, Scionti L, Vermigli C, Seguro R, Mancini L, Ghirlanda G. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up. Int J Low Extrem Wounds 2011 ; 10: 80 - 5.
7. Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng 2006 ; 12: 2407 - 24. Review.
8. Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003 ; 26: 1701 - 5.
9. Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O'Connell SM, Steinberg J, Falanga V. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen 2006 ; 14: 102 - 9. Review.
10. Wong T, McGrath JA, Navsaria H. The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 2007 ; 156: 1149 - 55.
11. Suzuki S, Kawai K, Ashoori F, Morimoto N, Nishimura Y, Ikada Y. Long-term follow-up study of artificial dermis composed of outer silicone layer and inner collagen sponge. Br J Plast Surg 2000 ; 53: 659 - 66.
12. Yannas IV, Orgill DP, Burke JF. Template for skin regeneration. Plast Reconstr Surg 2011 ; 127 (Suppl 1): 60S - 70S. Review.
13. Morimoto N, Saso Y, Tomihata K, Taira T, Takahashi Y, Ohta M, Suzuki S. Viability and function of autologous and allogeneic fibroblasts seeded in dermal substitutes after implantation. J Surg Res 2005 ; 125: 56 - 67.
14. Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol 2008 ; 52: 1023 - 32. Review.
15. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004 ; 32: 1212 - 25.
16. Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther 2002 ; 13: 1605 - 10.
17. Morimoto N, Takemoto S, Kanda N, Ayvazyan A, Taira MT, Suzuki S. The utilization of animal product-free media and autologous serum in an autologous dermal substitute culture. J Surg Res 2011 ; 171: 339 - 46.
18. Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, Tamaki K, Hirakata H, Ohmura T, Furue M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 2009 ; 19: 461 - 8.
19. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009 ; 122: 3209 - 13. Review.
20. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997 ; 276: 75 - 81.
21. Sanada H, Iizaka S, Matsui Y, Furue M, Tachibana T, Nakayama T, Sugama J, Furuta K, Tachi M, Tokunaga K, Miyachi Y ; Scientific Education Committee of the Japanese Society of Pressure Ulcers. Clinical wound assessment using DESIGN-R total score can predict pressure ulcer healing: pooled analysis from two multicenter cohort studies. Wound Repair Regen 2011 ; 19: 559 - 67.
22. Sanada H, Moriguchi T, Miyachi Y, Ohura T, Nakajo T, Tokunaga K, Fukui M, Sugama J, Kitagawa A. Reliability and validity of DESIGN, a tool that classifies pressure ulcer severity and monitors healing. J Wound Care 2004 ; 13: 13 - 8.
23. Matsui Y, Furue M, Sanada H, Tachibana T, Nakayama T, Sugama J, Furuta K, Tachi M, Tokunaga K, Miyachi Y. Development of the DESIGN-R with an observational study: an absolute evaluation tool for monitoring pressure ulcer wound healing. Wound Repair Regen 2011 ; 19: 309 - 15.
24. Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res. 2009 ; 9: 115. Review.
25. Veves A, Falanga V, Armstrong DG, Sabolinski ML ; Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001 ; 24: 290 - 5.
26. Brem H, Balledux J, Bloom T, Kerstein MD, Hollier L. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch Surg 2000 ; 135: 627 - 34.
27. Curran MP, Plosker GL. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. BioDrugs 2002 ; 16: 439 - 55. Review.
28. Dinh TL, Veves A. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg 2006 ; 117 (7 Suppl): 152S - 157S. Review.
29. Marston WA, Hanft J, Norwood P, Pollak R. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003 ; 26: 1701 - 5.
30. Miwa H, Hashimoto Y, Tensho K, Wakitani S, Takagi M. Xeno-free proliferation of human bone marrow mesenchymal stem cells. Cytotechnology 2012 ; 64: 301 - 8.